Skip to main content

Peer Review reports

From: Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial—a study protocol

Original Submission
23 Jan 2023 Submitted Original manuscript
25 Apr 2023 Author responded Author comments - Yasmin A. Civil
Resubmission - Version 2
25 Apr 2023 Submitted Manuscript version 2
3 May 2023 Editorially accepted
9 May 2023 Article published 10.1186/s12885-023-10910-6

You can find further information about peer review here.

Back to article page